Viewing Study NCT04995094

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 1:33 AM

Ignite Modification Date: 2025-12-25 @ 11:47 PM

Study NCT ID: NCT04995094

Status: WITHDRAWN

Last Update Posted: 2021-11-05

First Post: 2021-07-19

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Study of Neoadjuvant Imprime PGG and Pembrolizumab for Stage III, Resectable Melanoma

Sponsor: HiberCell, Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module